Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension

Journal of Hypertension

Volumn 16, Issue 12, 1998, Pages 1789-1796

  Grassi, Guido ^a,b   Turri, Carlo ^b   Dell'Oro, Raffaella ^a,b   Stella, Maria Luisa ^b   Bolla, Gianni B ^b   Mancia, Giuseppe ^a,b,c  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

Author keywords

Angiotensin converting enzyme inhibitors; Baroreflex; Renin angiotensin system; Sympathetic nervous system

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE; LISINOPRIL; NITROPRUSSIDE SODIUM; NORADRENALIN; PHENYLEPHRINE; RENIN;

ADRENERGIC SYSTEM; ADULT; ARTICLE; BRADYCARDIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ESSENTIAL HYPERTENSION; HEART RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MEAN ARTERIAL PRESSURE; NORADRENALIN BLOOD LEVEL; ORAL DRUG ADMINISTRATION; PERONEUS NERVE; PLASMA RENIN ACTIVITY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TACHYCARDIA;

EID: 0031766112     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816120-00012     Document Type: Article

References (44)

1. Zimmerman BG, Sybertz EJ, Wong PC. Interaction between sympathetic and renin angiotensin system. J Hypertens 1984; 2:581-587.
2. Mancia G, Saino A, Grassi G. Interactions between the sympathetic nervous system and the renin-angiotensin system. In: Laragh J, Brenner B (editors): Hypertension: pathophysiology, diagnosis and management. New York: Raven Press; 1995. pp. 399-407.
3. Antonaccio MJ, Kerwin L. Pre- and postganglionic inhibition of vascular sympathetic function by captopril in SHR. Hypertension 1981; 3 (suppl I): 54-62.
4. Majewski HI, Hedler L, Schurr C, Starke K. Modulation of noradrenaline release in pithed rabbit: a role for angiotensin II. J Cardiovasc Pharmacol 1984; 6:888-896.
5. Berececk KH, Kirk KA, Nagahama S, Oparil S. Sympathetic function in spontaneously hypertensive rats after chronic administration of captopril. Am J Physiol 1987; 252:H796-H806.
6. Reid IA. Actions of angiotensin II on the brain: mechanisms and physiological role. Am J Physiol 1984; 246:F533-F543.
7. Degli Esposti E, Chiarini C, Masi A, Santoro A, Sturani A, Umile A, et al. The effects of captopril on blood pressure in essential hypertensive patients with low or normal renin activity. Clin Exp Hypertens 1981; 3:439-454.
8. Weinberger MH. Role of sympathetic nervous system activity in the blood pressure response to long-term captopril therapy in severely hypertensive patients. Am J Cardiol 1982; 49:1542-1544.
9. Morioka S, Simon G, Conn JN. Cardiac and hormonal effects of enalapril in hypertension. Clin Pharmacol Ther 1983; 34:583-589.
10. Mitchell HC, Pettinger WA, Gianotti L, Reed G, Kirk L, Kuhnert LV. Further studies on the hypernoradrenergic state of treated hypertensives. Clin Exp Hypertens 1983; 5:1611-1627.
11. Valles PM, Matas SM, Bronsoks A, Mate BG, Torguet E, Mauri N. Quinapril ACE-inhibition effects on adrenergic parameters in moderate essential hypertension. Kidney Int 1996; 12 (suppl 55):S104-S106.
12. Morganti A, Grassi G, Giannattasio C, Bolla GB, Turolo L, Saino A, et al. Effect of angiotensin converting enzyme inhibition on cardiovascular regulation during reflex sympathetic activation in sodium-repleted patients with essential hypertension. J Hypertens 1989; 7:825-835.
13. Giannattasio C, Cattaneo BM, Omboni S, Seravalle G, Bolla GB, Turolo L, et al. Sympathomoderating influence of benazepril in essential hypertension. J Hypertens 1992; 10:373-378.
14. Noll G, Wenzel RR, De Marchi S, Shaw S, Lüscher TF. Differential effects of captopril and nitrates on muscle sympathetic nerve activity in volunteers. Circulation 1997; 95:2286-2292.
15. Grassi G, Mancia G. Arterial baroreflexes and other cardiovascular reflexes in hypertension. In: Swales JD (editor): Textbook of hypertension. Oxford: Blackwell Scientific Publications; 1994. pp. 394-408.
16. Parati G, Casadei R, Groppelli A, Di Rienzo M, Mancia G. Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing. Hypertension 1989; 13:647-655.
17. Vallbo AB, Hagbarth KE, Torebjörk HE, Wallin BG. Somatosensory, proprioceptive and sympathetic activity in human peripheral nerves. Physiol Rev1979; 59:919-957.
18. Grassi G, Seravalle G, Cattaneo BM, Lanfranchi A, Vailati S, Giannattasio C, et al. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation 1995; 92:3206-3211.
19. Sundlof G, Wallin BG. The variability of muscle nerve sympathetic activity in resting recumbent man. J Physiol (Lond) 1977; 272:383-397.
20. Grassi G, Bolla GB, Seravalle G, Turn C, Lanfranchi A, Mancia G. Comparison between reproducibility and sensitivity of muscle sympathetic nerve traffic and plasma noradrenaline in man. Clin Sci 1997; 92:285-289.
21. Hjemdahl P, Daleskog M, Kahan T. Determination of plasma catecholamines by high-performance liquid chromatography with a radioenzymatic method. Life Sci 1979; 25:131-138.
22. Sealey JE, Laragh JH. How to do a plasma renin assay. Cardiovasc Med 1977; 2:1079-1092.
23. Mancia G, Mark AL. Arterial baroreflexes in humans. In: Shepherd JT, Abboud FM (editors): Handbook of physiology, sect 2, The cardiovascular system, vol III, part 2. Bethesda, Maryland: American Physiological Society; 1983. pp. 755-793.
24. Zimmerman BG, Gomer SK, Chia LJ. Action of angiotensin on vascular adrenergic nerve endings: facilitation of norepinephrine release. Fed Proc 1972; 31:1344-1350.
25. Lewis GP, Reit E. The action of angiotensin and bradykinin on the superior cervical ganglion of the cat. J Physiol (Lond) 1965; 179:538-553.
26. Bravo EL, Tarazi RC. Converting enzyme inhibition with an orally active compound in hypertensive man. Hypertension 1979; 1:39-52.
27. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Pozzi M, Morganti A, et al. Effects of chronic ACE-inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation 1997; 96:1173-1179.
28. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Mancia G. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension 1998; 31:68-72.
29. Matsukawa T, Gotoh E, Minamisawa K, Kihara M, Ueda SI, Shionoiri H, et al. Effects of intravenous infusions of angiotensin II on muscle sympathetic nerve activity in humans. Am J Physiol 1991; 261:R690-R696.
30. Lumbers ER, McCloskey DI, Potter EK. Inhibition by angiotensin II of baroreceptor-evoked activity in cardiac vagal efferent nerves in the dog. J Physiol (Lond) 1979; 249:69-80.
31. Guo GB, Abboud FM. Angiotensin II attenuates baroreflex control of heart rate and sympathetic activity. Am J Physiol 1984; 246:H80-H89.
32. Mace PJE, Watson RDS, Skan W, Littler WA. Inhibition of the baroreceptor heart rate reflex by angiotensin II in normal man. Cardiovasc Res 1985; 19:525-527.
33. Matsukawa T, Gotoh E, Miyajima E, Yamada Y, Shinori H, Tochikubo O, et al. Angiotensin II inhibits baroreflex control of muscle sympathetic nerve activity and the heart rate in patients with essential hypertension. J Hypertens 1988; 6 (suppl 4):S501-S504.
34. Osterziel KJ, Röhrig N, Dietz R, Manthey J, Hecht J, Kubler W. Influence of captopril on the arterial baroreceptor reflex in patients with heart failure. Eur Heart J 1988; 9:1137-1145.
35. Osterziel KJ, Dietz R, Schmid W, Mikulaschek K, Manthey J, Kubler W. ACE-inhibition improves vagal reactivity in patients with heart failure. Am Heart J 1990; 120:1120-1129.
36. Stein RD, Stephenson RB, Weaver LC. Central actions of angiotensin II oppose baroreceptor-induced sympathoinhibition. Am J Physiol 1984; 246:R13-R19.
37. Mancia G, Parati G, Pomidossi G, Grassi G, Bertinieri G, Buccino N, et al. Modification of arterial baroreflexes by captopril in essential hypertension. Am J Cardiol 1982; 49:1415-1419.
38. Ibsen H, Egan B, Osterziel K, Vander A, Julius S. Reflex-hemodynamic adjustments and baroreflex sensitivity during converting enzyme inhibition with MK-421 in normal humans. Hypertension 1983; 5:184-191.
39. Grassi G, Colombo M, Seravalle G, Spaziani D, Mancia G. Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity and congestive heart failure. Hypertension 1998; 31:64-67.
40. Delius W, Hagbarth KE, Hongell A, Wallin BG. Manoeuvres affecting sympathetic outflow in human muscle nerves. Acta Physiol Scand 1972; 84:82-94.
41. Morlin C, Wallin BG, Eriksson BM. Muscle sympathetic activity and plasma noradrenaline in normotensive and hypertensive man. Acta Physiol Scand 1983; 119:117-121.
42. Ferguson DW, Berg WJ, Sanders JS. Clinical and hemodynamic correlates of sympathetic neural activity in normal humans and patients with heart failure: evidence from direct microneurographic recordings. J Am Coll Cardiol 1990; 16:1125-1134.
43. Esler M, Jennings G, Lambert G, Meredith I, Home M, Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate and functions. Physiol Rev 1990; 70:963-985.
44. Esler M. Sympathetic activity in experimental and human hypertension. In: Zanchetti A, Mancia G (editors): Handbook of hypertension, vol 17, pathophysiology of hypertension. Amsterdam: Elsevier Science; 1997. pp. 628-673.